Oscar Health (OSCR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Meeting opened with a welcome and a reminder about forward-looking statements and non-GAAP measures.
Introduction of board members, executive officers, and independent auditor.
Agenda and rules of conduct were made available to stockholders, with voting eligibility and procedures outlined.
Board and executive committee updates
Sid Sankaran announced as incoming Board Chair, succeeding Jeffery Boyd.
Board and executive team members introduced, highlighting leadership continuity.
Shareholder proposals
Three proposals presented: election of directors, advisory approval of executive compensation, and ratification of the independent auditor.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Oscar Health
- AI, transparency, and financial incentives are reshaping consumer-driven healthcare strategies.OSCR
7th Annual Healthcare Symposium9 Jul 2026 - Q1 2025 revenue up 42%, net income up 55%, and membership exceeded 2 million.OSCR
Q1 20259 Jul 2026 - 2025 revenue up 28% with record membership; 2026 targets profitability and margin gains.OSCR
Q4 20258 Jul 2026 - Three-year plan targets 20% revenue CAGR, 5% margin, and ICHRA-driven growth, powered by technology.OSCR
Investor Day 20248 Jul 2026 - Strong 2026 performance, favorable trends, and AI-driven integrity shape a stable outlook.OSCR
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Revenue and net income soared, membership surged, but regulatory risks persist.OSCR
Q1 20267 May 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and robust governance practices.OSCR
Proxy filing23 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the June 2026 meeting.OSCR
Proxy filing23 Apr 2026 - Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026